BASEL, Switzerland, March 23, 2026 (GLOBE NEWSWIRE) — Anaveon, a late-stage preclinical biotech focused on reprogramming the immune system with precision biologics, announces today the appointment of Thaminda Ramanayake as its new Chief Executive Officer. Mr. Ramanayake brings over 20 years of global biopharmaceutical leadership…
Latest News
Editor' Pick
This communication relates solely to the investment activities of the mentioned Special…
Just In
U.S. President Donald Trump says the United States is “getting very close”…
Canada News
More than two years after a Toronto father vanished without a trace, his sister is speaking out, pleading for answers as police continue to…
Lifestyle
A newly released Statistics Canada study has found that nearly 40 per cent of Canadian youth appear to be exceeding…
Tech & Innovation
Lux Optics co-founder Sebastiaan de With made headlines when he joined Apple in late January. The company was behind Halide, one of the most popular photography…
Entertainment
Dakota Mortensen is seeking a protective order against his ex-girlfriend Taylor Frankie…
